Home
Categories
EXPLORE
True Crime
Society & Culture
Comedy
Music
Religion & Spirituality
Business
Health & Fitness
About Us
Contact Us
Copyright
© 2024 PodJoint
Loading...
0:00 / 0:00
Podjoint Logo
TT
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/bd/e9/a5/bde9a51c-5334-d453-b6e2-78f72963acbf/mza_12497236634948696431.jpg/600x600bb.jpg
Dive into Imaging Science
European Society for Molecular Imaging (ESMI)
17 episodes
3 weeks ago
GUEST: Rodney Hicks, MelbourneWelcome to Episode 17 of “Dive into Imaging Science”! 🎧 Tune in for a dynamic discussion on how NETTER-2 may reshape treatment strategies for neuroendocrine tumours, what it means for the wider field of theranostics, and where radioligand therapy is headed next. For our seventeenth edition, we are at the stunning Certosa di Pontignano in Tuscany – the home of TOPIM, which focussed this year on Theranostics. 🎯 Suitably, we discuss one of the most important r...
Show more...
Life Sciences
Science,
Natural Sciences,
Physics
RSS
All content for Dive into Imaging Science is the property of European Society for Molecular Imaging (ESMI) and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
GUEST: Rodney Hicks, MelbourneWelcome to Episode 17 of “Dive into Imaging Science”! 🎧 Tune in for a dynamic discussion on how NETTER-2 may reshape treatment strategies for neuroendocrine tumours, what it means for the wider field of theranostics, and where radioligand therapy is headed next. For our seventeenth edition, we are at the stunning Certosa di Pontignano in Tuscany – the home of TOPIM, which focussed this year on Theranostics. 🎯 Suitably, we discuss one of the most important r...
Show more...
Life Sciences
Science,
Natural Sciences,
Physics
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/bd/e9/a5/bde9a51c-5334-d453-b6e2-78f72963acbf/mza_12497236634948696431.jpg/600x600bb.jpg
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours
Dive into Imaging Science
55 minutes
4 weeks ago
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours
GUEST: Rodney Hicks, MelbourneWelcome to Episode 17 of “Dive into Imaging Science”! 🎧 Tune in for a dynamic discussion on how NETTER-2 may reshape treatment strategies for neuroendocrine tumours, what it means for the wider field of theranostics, and where radioligand therapy is headed next. For our seventeenth edition, we are at the stunning Certosa di Pontignano in Tuscany – the home of TOPIM, which focussed this year on Theranostics. 🎯 Suitably, we discuss one of the most important r...
Dive into Imaging Science
GUEST: Rodney Hicks, MelbourneWelcome to Episode 17 of “Dive into Imaging Science”! 🎧 Tune in for a dynamic discussion on how NETTER-2 may reshape treatment strategies for neuroendocrine tumours, what it means for the wider field of theranostics, and where radioligand therapy is headed next. For our seventeenth edition, we are at the stunning Certosa di Pontignano in Tuscany – the home of TOPIM, which focussed this year on Theranostics. 🎯 Suitably, we discuss one of the most important r...